Neural Analytics, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Neural Analytics, Inc. makes
Neural Analytics, Inc. manufactures the Lucid M1 Transcranial Doppler Ultrasound System, a device equipped with 2MHz transducers for non-invasive monitoring of cerebral blood flow. The company also produces the NeuralBot, a robotic system designed for medical applications requiring precision and automation.
The Lucid M1 System and NeuralBot are classified as Class II medical devices under FDA regulations, with both products listed via the 510(k) pathway. The company is based in the United States.
Catalogue
- Regimes: 510(k) Registry: 510(k)
NeuralBot Ref K180455
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Neural Analytics, Inc. have in the registry?
The registry currently lists 2 devices for Neural Analytics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Neural Analytics, Inc.'s devices?
Among its 2 most recently registered devices, Neural Analytics, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Neural Analytics, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Neural Analytics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Neural Analytics, Inc. in the registry?
The most recently registered devices listed for Neural Analytics, Inc. include Lucid M1 Transcranial Doppler Ultrasound System (Lucid M1 System) with 2MHz Transducers and NeuralBot.